Coronary atherosclerosis can regress with very intensive statin therapy

Ilke Sipahi, MD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Stephen J. Nicholls, MBBS, PhD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

E. Murat Tuzcu, MD
Vice Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Steven E. Nissen, MD
Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; president, American College of Cardiology; principal investigator, ASTEROID trial

Address: Ilke Sipahi, MD, Department of Cardiovascular Medicine, JJ65, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail sipahii@ccf.org

Dr. Sipahi has received an educational grant from Pfizer.

Dr. Nicholls has received lecture honoraria from AstraZeneca and Pfizer.

Dr. Tuzcu received grant support from Pfizer and Takeda and lecture honoraria from Pfizer.

Dr. Nissen has received research support from AstraZeneca, Eli Lilly, Pfizer, Takeda, Sankyo, and Sanofi-Aventis. He has also consulted for a number of pharmaceutical companies without financial compensation. All his honoraria, consulting fees, or other payments from any for-profit entity are paid directly to charity, so that neither income nor tax deduction is received.

Ilke Sipahi, MD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Stephen J. Nicholls, MBBS, PhD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

E. Murat Tuzcu, MD
Vice Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Steven E. Nissen, MD
Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; president, American College of Cardiology; principal investigator, ASTEROID trial

Address: Ilke Sipahi, MD, Department of Cardiovascular Medicine, JJ65, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail sipahii@ccf.org

Dr. Sipahi has received an educational grant from Pfizer.

Dr. Nicholls has received lecture honoraria from AstraZeneca and Pfizer.

Dr. Tuzcu received grant support from Pfizer and Takeda and lecture honoraria from Pfizer.

Dr. Nissen has received research support from AstraZeneca, Eli Lilly, Pfizer, Takeda, Sankyo, and Sanofi-Aventis. He has also consulted for a number of pharmaceutical companies without financial compensation. All his honoraria, consulting fees, or other payments from any for-profit entity are paid directly to charity, so that neither income nor tax deduction is received.

Ilke Sipahi, MD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Stephen J. Nicholls, MBBS, PhD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

E. Murat Tuzcu, MD
Vice Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Steven E. Nissen, MD
Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; president, American College of Cardiology; principal investigator, ASTEROID trial

Address: Ilke Sipahi, MD, Department of Cardiovascular Medicine, JJ65, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail sipahii@ccf.org

Dr. Sipahi has received an educational grant from Pfizer.

Dr. Nicholls has received lecture honoraria from AstraZeneca and Pfizer.

Dr. Tuzcu received grant support from Pfizer and Takeda and lecture honoraria from Pfizer.

Dr. Nissen has received research support from AstraZeneca, Eli Lilly, Pfizer, Takeda, Sankyo, and Sanofi-Aventis. He has also consulted for a number of pharmaceutical companies without financial compensation. All his honoraria, consulting fees, or other payments from any for-profit entity are paid directly to charity, so that neither income nor tax deduction is received.